======= AASDH =======
== Gene Information ==
* **Official Symbol**: AASDH
* **Official Name**: aminoadipate-semialdehyde dehydrogenase
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=132949|132949]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q4L235|Q4L235]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=AASDH&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20AASDH|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/614365|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of the non-ribosome peptide syntesase (NRPS) enzyme family. The encoded protein contains an AMP-binding domain, PP-binding (phosphopantetheine, or pantetheine 4'phosphate-binding) domain and the Pyrrolo-quinoline quinon (PQQ) binding domain. The protein is expressed in several adult tissues. [provided by RefSeq, Apr 2016].
* **UniProt Summary**: N/A
|AMP-binding|
|PP-binding|
|amino acid activation for nonribosomal peptide biosynthetic process|
|acid-thiol ligase activity|
|beta-alanine metabolic process|
|nonribosomal peptide biosynthetic process|
|amino acid activation|
|neurotransmitter metabolic process|
|cellular amino acid metabolic process|
|fatty acid metabolic process|
|regulation of neurotransmitter levels|
|peptide biosynthetic process|
|amide biosynthetic process|
|peptide metabolic process|
|monocarboxylic acid metabolic process|
|cellular amide metabolic process|
|carboxylic acid metabolic process|
|cellular lipid metabolic process|
|oxoacid metabolic process|
|organic acid metabolic process|
|lipid metabolic process|
|organonitrogen compound biosynthetic process|
|ATP binding|
|cellular nitrogen compound biosynthetic process|
|small molecule metabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|-1.91|
|[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|1.71|
|[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|1.74|
|[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|1.75|
|[[:results:exp319|ABT-702 5μM plus Dimethyloxaloylglycine 11μM R07 exp319]]|1.76|
|[[:results:exp493|IL-3 9ng/ml R08 exp493]]|1.77|
|[[:results:exp435|JQ1 0.8μM R08 exp435]]|1.82|
|[[:results:exp448|Ammonium tetrathiomolybdate 10μM R08 exp448]]|1.83|
|[[:results:exp278|CVT-10216 0.1μM R06 exp278]]|1.83|
|[[:results:exp442|Ibrutinib 10μM R08 exp442]]|1.86|
|[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|1.86|
|[[:results:exp360|Genistein 15μM R07 exp360]]|1.88|
|[[:results:exp464|Calcipotriol 5μM R08 exp464]]|1.89|
|[[:results:exp425|Beta-Estradiol 0.55μM R07 exp425]]|2.02|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 16643
* **Expression level (log2 read counts)**: 4.37
{{:chemogenomics:nalm6 dist.png?nolink |}}